| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNICAMPANIAVAN00104198 |
|
|
Titolo |
Mittag-Leffler functions, related topics and applications / Rudolf Gorenflo ... [ et al.] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
|
|
|
|
Titolo uniforme |
Mittag-Leffler functions, related topics and applications |
|
|
|
|
|
Descrizione fisica |
|
XIV, 443 p. : ill. ; 24 cm |
|
|
|
|
|
|
Soggetti |
|
26A33 - Fractional derivatives and integrals [MSC 2020] |
33E12 - Mittag-Leffler functions and generalizations [MSC 2020] |
34A08 - Fractional ordinary differential equations and fractional differential inclusions [MSC 2020] |
44-XX - Integral transforms, operational calculus [MSC 2020] |
45Kxx - Integro-partial differential equations [MSC 2020] |
60G22 - Fractional processes, including fractional Brownian motion [MSC 2020] |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910576874303321 |
|
|
Autore |
Meegan Mary J |
|
|
Titolo |
Anticancer Drugs 2021 |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (594 p.) |
|
|
|
|
|
|
Soggetti |
|
Chemistry |
Research & information: general |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
The Special Issue "Anticancer Drugs 2021" of Pharmaceuticals is focused on recent significant advances in the design, synthesis, molecular mechanism of action and therapeutic applications of anticancer drugs. This collection of preclinical research papers and reviews includes designed chemotherapeutic agents, targeted therapies and biological agents. The rationalization for the biological activity of these drugs is presented, which helps to guide the design of more effective agents. Structure-activity relationships, together with the biological context in which targets are selected for oncology drug development, are also considered. |
|
|
|
|
|
|
|
| |